Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA, Inc.
Ahmedabad, India, August 13, 2025 – Senores Pharmaceuticals Limited (“SPL”), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (“SPI”), has signed an agreement today to acquire two products of USFDA-approved Abbreviated New Drug Applications (“ANDAs”) from Teva Pharmaceuticals USA, Inc. The addressable opportunity of the acquired ANDAs in the USA is